AZN vs NRIX · P/E 28, $288.38B cap vs rev $15.3M
AstraZeneca PLC (AZN) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported NRIX revenue for 2026-05-31 was $15.3M. Net income was -$176.7M. NRIX currently screens at market cap $1.77B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the AZN and NRIX stock pages for the full models.
Not investment advice.